4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Scientific Knowledge and Technology, Animal Experimentation, and Pharmaceutical Development.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Human discovery of pharmacologically active substances is arguably the oldest of the biomedical sciences with origins >3500 years ago. Since ancient times, four major transformations have dramatically impacted pharmaceutical development, each driven by advances in scientific knowledge, technology, and/or regulation: (1) anesthesia, analgesia, and antisepsis; (2) medicinal chemistry; (3) regulatory toxicology; and (4) targeted drug discovery. Animal experimentation in pharmaceutical development is a modern phenomenon dating from the 20th century and enabling several of the four transformations. While each transformation resulted in more effective and/or safer pharmaceuticals, overall attrition, cycle time, cost, numbers of animals used, and low probability of success for new products remain concerns, and pharmaceutical development remains a very high risk business proposition. In this manuscript we review pharmaceutical development since ancient times, describe its coevolution with animal experimentation, and attempt to predict the characteristics of future transformations.

          Related collections

          Author and article information

          Journal
          ILAR J
          ILAR journal
          Oxford University Press (OUP)
          1930-6180
          1084-2020
          December 2016
          : 57
          : 2
          Affiliations
          [1 ] Lewis B. Kinter, PhD, DABT, FATS is Principle Scientist at GLP Scientific Consulting in Unionville, Pennsylvania. Joseph J. DeGeorge, PhD, is Vice President of Safety Assessment and Laboratory Animal Resource at Merck & Co., Inc. in West Point, Pennsylvania.
          Article
          ilw027
          10.1093/ilar/ilw027
          28053064
          ef6ce5d8-07c2-4eec-8fab-5ba830ee4f3e
          History

          pharmacology and toxicology,regulation,technology,animal and human experimentation,pharmaceutical development

          Comments

          Comment on this article